DuPont de Nemours, Inc.
NYSE:DDChemicals - Specialty
-$0.26 today
- Market cap
- $19.91B
- Beta
- 1.08
- P/E (TTM)
- -674.4
- EPS (TTM)
- -$0.07
- Dividend yield
- 1.62%
Volume 1.33M
Average 3.65M
DD EBITDA Margin
EBITDA as a percentage of revenue.
DuPont de Nemours, Inc.NYSE: DD
EBITDA Margin · Q2 FY2026 · quarter ended Jun 2026
EBITDA Margin narrows to 19.7%
EBITDA Margin was 19.7% in Q2 FY2026, down 1.3 pp from a year earlier. On a trailing-twelve-month basis it was 18.2%, up 2.8 pp year over year. Over 3 fiscal years it narrowed by 6.7 pp.
Context
- EBITDA Margin widened in 1 of the last 3 fiscal years.
- FY2025 was the lowest level in the 4 fiscal years shown.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 10 analysts of 34.4% for the fiscal year ending Dec 2026, up from 16.9% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- 19.7%+1.5 pp QoQ
- Last fiscal yearDec 2025
- 16.9%-5.3 pp YoY
- LTMJun 2026
- 18.2%+2.8 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -1.3 pp | +8.3 pp | +9.7 pp |
| 1 year | -5.3 pp | +17.5 pp | +22.7 pp |
| 3 years | -6.7 pp | +18.5 pp | +25.2 pp |
| 5 years | — | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 16.9%
- Year-over-year change
- -5.3pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 16.9% | -5.3pp |
| FY2024 | 2024-12-31 | 22.2% | +5.3pp |
| FY2023 | 2023-12-31 | 17.0% | -6.7pp |
| FY2022 | 2022-12-31 | 23.6% | -0.9pp |
| FY2021 | 2021-12-31 | 24.5% | — |
EBITDA Margin vs competitors
How DD compares with its peers on the latest reported figures
- DD's LTM Jun 2026 EBITDA Margin of 18.2% is the 2nd highest of the 9 companies compared; the peer median is 12.5%.
- Its year-over-year change of +2.8 pp is the 2nd highest of 9, against a peer median of -0.3 pp.
- Over three fiscal years its change of -6.7 pp compares with a peer median of -7.8 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Sep 2026 | 24.2% | -1.5 pp | -0.3 pp | |
| LTM Jun 2026 | 18.2% | +2.8 pp | -6.7 pp | |
| LTM Sep 2026 | 14.8% | +1.7 pp | +6.6 pp | |
| LTM Jun 2026 | 14.3% | -4.2 pp | -0.8 pp | |
| LTM Sep 2026 | 13.4% | -5.7 pp | -6.9 pp | |
| LTM Sep 2026 | 11.7% | +10.2 pp | -8.6 pp | |
| LTM Sep 2026 | 8.2% | +0.9 pp | -13.7 pp | |
| LTM Jun 2026 | 4.0% | +1.4 pp | -20.3 pp | |
| LTM Jun 2026 | -2.9% | -8.3 pp | -11.8 pp | |
| Peer median (excluding DD) | 12.5% | -0.3 pp | -7.8 pp | |
Competitors are the stored peer set for DD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 12.57B | 13.02B | 12.07B | 12.39B | 6.85B |
| Cost of Revenue | 8.54B | 8.99B | 8.44B | 8.47B | 4.78B |
| Gross Profit | 4.03B | 4.03B | 3.63B | 3.91B | 2.07B |
| Gross Margin | 32.1% | 30.9% | 30.1% | 31.6% | 30.3% |
| Research & Development | 557M | 536M | 508M | 531M | 193M |
| Selling, General & Admin | 1.6B | 1.47B | 1.41B | 1.55B | 1.02B |
| Operating Expenses | 2.16B | 2B | 1.92B | 2.08B | 1.21B |
| Depreciation & Amortization | 1.11B | 1.14B | 1.15B | 1.19B | 647M |
| EBITDA | 3.08B | 3.08B | 2.05B | 2.75B | 1.16B |
| EBITDA Margin | 24.5% | 23.6% | 17.0% | 22.2% | 16.9% |
| Operating Income | 1.87B | 2.02B | 1.72B | 1.83B | 860M |
| Operating Margin | 14.9% | 15.5% | 14.2% | 14.8% | 12.6% |
| Interest Income | 12M | 50M | 155M | 73M | 98M |
| Interest Expense | 525M | 492M | 396M | 366M | 313M |
| Other Income / Expenses | (426M) | (574M) | (1.21B) | (637M) | (660M) |
| Income Before Tax | 1.44B | 1.45B | 504M | 1.19B | 200M |
| Pre-Tax Margin | 11.5% | 11.1% | 4.2% | 9.6% | 2.9% |
| Income Tax Expense | 237M | 387M | (29M) | 414M | 102M |
| Net Income | 6.47B | 5.87B | 423M | 703M | (779M) |
| Net Margin | 51.5% | 45.1% | 3.5% | 5.7% | -11.4% |
| EPS (Basic) | 35.76 | 34.89 | 2.82 | 5.04 | (5.61) |
| EPS (Diluted) | 35.64 | 34.83 | 2.82 | 5.04 | (5.58) |
| Weighted Avg Shares | 180.9M | 166.17M | 149.97M | 139.73M | 139.17M |
| Weighted Avg Shares (Diluted) | 181.4M | 166.47M | 150.4M | 140.2M | 139.73M |
DuPont de Nemours, Inc.
NYSE:DD
Intrinsic Alpha fair value
Locked
Current Price
$150.23
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.